Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Alia Therapeutics
Italy
B
1-10 Employees
2018
Key takeaway
Alia Therapeutics is focused on developing next-generation gene editing medicines aimed at curing rare genetic diseases by directly correcting genetic errors in patients' cells.
Reference
Core business
Our company - Alia Therapeutics
Alia Therapeutics Srl is an Italian biotech start-up which mission is to develop innovative treatments for incurable genetic diseases using gene editing technology.
Genespire
Milan, Italy
B
1-10 Employees
2020
Key takeaway
Genespire specializes in developing innovative gene therapies aimed at curing severe diseases. Their approach utilizes advanced lentiviral vector platforms, providing potential for stable and prolonged expression of therapeutic genes through a one-time treatment.
Reference
Core business
The company - Genespire
Genenta Science
Milan, Italy
B
1-10 Employees
2014
Key takeaway
Genenta is a clinical-stage biotechnology company focused on developing innovative cell and gene therapies for cancer, particularly through its lead product, Temferon™, which utilizes hematopoietic stem cells to deliver interferon-alpha directly to tumors. This targeted approach aims to enhance immune responses while minimizing systemic toxicity, addressing intrinsic immunological resistance that often limits the effectiveness of traditional cancer treatments.
Reference
Core business
Genenta science | Genenta science
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
InnovaVector
Pozzuoli, Italy
B
11-50 Employees
2019
Key takeaway
InnovaVector specializes in the development and production of Adeno-Associated Viral (AAV) vectors for both non-clinical and clinical applications, playing a crucial role in advancing gene therapy from research to market. With over twenty years of expertise, the company is well-equipped to meet the growing demand for high-quality GMP AAV batches, thereby facilitating the development of new gene therapies.
Reference
Product
GMP Production - Innovavector
I-Gene Project
Italy
B
1-10 Employees
-
Key takeaway
The I-GENE project focuses on innovative gene therapy approaches, utilizing nanotransducers for precise gene editing. By employing advanced technologies, the project aims to enhance the safety and efficacy of gene therapy, particularly for treating conditions like melanoma.
Reference
Core business
I-GENE project: gene therapy, nanomedicine, photonics, material science
I-GENE project proposesa new concept of genome editing, aiming to make safe previously impracticable applications of gene therapy.
NanoPhoria
Milan, Italy
B
1-10 Employees
2022
Key takeaway
NanoPhoria is a preclinical biotech company focused on innovative delivery methods for biologics, including therapeutic peptides and RNAs. Their lead product, NP-MP1, utilizes a non-viral nano-delivery system for inhalable treatments, specifically targeting heart failure.
Reference
Core business
Home - NanoPhoria bioscience
AAVantgarde Bio
Milan, Italy
B
- Employees
2021
Key takeaway
AAVantgarde Bio is a clinical-stage biotechnology company that has developed innovative Adeno-Associated Viral (AAV) vector platforms specifically designed to enhance gene therapy. Their technology is currently being clinically validated for inherited retinal diseases, which highlights its potential for broader applications in gene therapy.
Reference
Core business
The company - AAVantgarde Bio
Reithera Srl
Rome, Italy
B
101-250 Employees
2005
Key takeaway
ReiThera is a biotech company specializing in the development and production of genetic vaccines and gene delivery technologies for advanced therapies, including those targeting major infectious diseases like hepatitis C, malaria, and HIV. With a strong focus on viral vector engineering and a cGMP production facility, ReiThera is well-equipped to support translational research and the manufacturing of innovative therapies.
Reference
Core business
An ideal partner for your translational research • Reithera
We develop and produce biopharmaceutical products for advanced therapies, in order to treat several serious or life-threatening diseases.
Altheia Science
Milan, Italy
B
1-10 Employees
2017
Key takeaway
Altheia Science is focused on developing innovative and curative gene therapies, particularly in the areas of autoimmunity and cancer. Their research emphasizes hematopoietic stem and progenitor cell (HSPC) gene therapy for various diseases, showcasing their commitment to advancing therapeutic approaches.
Reference
Core business
Altheia Science: Towards curative medicine
Our Mission is transforming the life of patients with autoimmune diseases throught innovative and curative cell and gene therapies.
Metis Precision Medicine
Turin, Italy
B
1-10 Employees
2017
Key takeaway
METIS is a B-corp focused on developing innovative cancer treatments through precision medicine, highlighting its commitment to advancing scientific knowledge and making new drugs, such as the potent anticancer drug "hOA-DN30," available for patients.
Reference
Core business
METIS – Precision Medicine
Technologies which have been searched by others and may be interesting for you:
When delving into the In Vivo Gene Therapy industry in Italy, several critical factors come into play. Regulatory frameworks are paramount, as the European Medicines Agency (EMA) governs approvals, necessitating compliance with stringent guidelines for safety and efficacy. Understanding Italy's unique legislative landscape, including any regional variations, is essential for navigating the approval process. Challenges in this sector often include high research and development costs, complex manufacturing processes, and the need for specialized facilities. However, Italy presents significant opportunities, particularly through its robust biotechnology sector and strong academic research institutions, fostering innovation and collaboration. The competitive landscape is marked by a mix of established pharmaceutical companies and emerging biotech firms, creating a dynamic environment ripe for partnerships and advancements. Environmental considerations are increasingly relevant, with a growing emphasis on sustainable practices in research and production. The global market for In Vivo Gene Therapy is expanding, driven by advancements in genetic research and increasing investments. This positions Italy as a key player, attracting international attention and collaborations. For those interested in this field, staying informed on technological advancements, funding opportunities, and market trends will be crucial to navigating the complexities of the industry effectively.
Some interesting numbers and facts about your company results for In Vivo Gene Therapy
| Country with most fitting companies | Italy |
| Amount of fitting manufacturers | 203 |
| Amount of suitable service providers | 139 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 2005 |
| Youngest suiting company | 2022 |
Some interesting questions that has been asked about the results you have just received for In Vivo Gene Therapy
What are related technologies to In Vivo Gene Therapy?
Based on our calculations related technologies to In Vivo Gene Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of In Vivo Gene Therapy?
Start-Ups who are working in In Vivo Gene Therapy are NanoPhoria
Which industries are mostly working on In Vivo Gene Therapy?
The most represented industries which are working in In Vivo Gene Therapy are Biotechnology, Other, Medical, Pharmaceuticals, Healthcare
How does ensun find these In Vivo Gene Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.